secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2024-09-03T23:59:59+00:00
Accession:  0000950170-24-102878
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Director John Jenkins adopts 10b5-1 plan to sell up to 5,436 CRBP shares
------------------------------------------------------------------------

- Plan covers up to 5,436 shares of common stock, effective November 30, 2024.
- Plan terminates on November 29, 2025, per Rule 10b5-1(c) affirmative defense.
- Dr. Jenkins is a member of the board of directors of Corbus Pharmaceuticals.
- Trading plan adopted on August 29, 2024; sales may begin after the 90-day cooling-off period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024102878/0000950170-24-102878-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000095017024102878/crbp-20240829.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-102878

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer